<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Freund E</submitter><funding>Bundesministerium f&amp;amp;amp;#x00FC;r Bildung und Forschung</funding><pagination>634</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6345938</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Metastatic colorectal cancer is the fourth most common cause of cancer death. Current options in palliation such as hyperthermic intraperitoneal chemotherapy (HIPEC) present severe side effects. Recent research efforts suggested the therapeutic use of oxidant-enriched liquid using cold physical plasma. To investigate a clinically accepted treatment regimen, we assessed the antitumor capacity of plasma-treated saline solution. In response to such liquid, CT26 murine colon cancer cells were readily oxidized and showed cell growth with subsequent apoptosis, cell cycle arrest, and upregulation of immunogenic cell death (ICD) markers in vitro. This was accompanied by marked morphological changes with re-arrangement of actin fibers and reduced motility. Induction of an epithelial-to-mesenchymal </pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo.</pubmed_title><pmcid>PMC6345938</pmcid><funding_grant_id>03Z22DN11</funding_grant_id><pubmed_authors>Freund E</pubmed_authors><pubmed_authors>Bekeschus S</pubmed_authors><pubmed_authors>Partecke LI</pubmed_authors><pubmed_authors>Heidecke CD</pubmed_authors><pubmed_authors>Liedtke KR</pubmed_authors><pubmed_authors>Metelmann HR</pubmed_authors><pubmed_authors>van der Linde J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo.</name><description>Metastatic colorectal cancer is the fourth most common cause of cancer death. Current options in palliation such as hyperthermic intraperitoneal chemotherapy (HIPEC) present severe side effects. Recent research efforts suggested the therapeutic use of oxidant-enriched liquid using cold physical plasma. To investigate a clinically accepted treatment regimen, we assessed the antitumor capacity of plasma-treated saline solution. In response to such liquid, CT26 murine colon cancer cells were readily oxidized and showed cell growth with subsequent apoptosis, cell cycle arrest, and upregulation of immunogenic cell death (ICD) markers in vitro. This was accompanied by marked morphological changes with re-arrangement of actin fibers and reduced motility. Induction of an epithelial-to-mesenchymal </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-04-26T08:51:20.636Z</modification><creation>2019-03-26T22:41:53Z</creation></dates><accession>S-EPMC6345938</accession><cross_references><pubmed>30679720</pubmed><doi>10.1038/s41598-018-37169-3</doi></cross_references></HashMap>